Preeclampsia Increases Cardiovascular Disease Risk After Pregnancy
Women who experience hypertensive disorders during pregnancy are at an increased risk for cardiovascular disorders later in life.
Cardiovascular Disease
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
Metformin Linked to Lower MACE Risk in Diabetes With CKD Progression
Continued monotherapy with metformin, compared with a sulfonylurea, is associated with a lower risk for major adverse cardiovascular events (MACE) among patients with type 2 diabetes who experienced reduced kidney function.
Heart Rate Recovery Linked to Sudden Cardiac Death Risk Regardless of LVEF
Investigators assessed whether cardiorespiratory fitness and heart rate recovery may predict a risk for sudden cardiac death independently of left ventricular ejection fraction.
Fixed-Dose Combination Polypill Effectively Prevents Major CV Events
A fixed-dose combination pill may be an effective component of a preventive strategy to reduce cardiovascular disease.
Biomarkers Identify Patients Who May Benefit From Ezetimibe Therapy
Investigators evaluated the risk for recurrent cardiovascular events and clinical benefit with ezetimibe.
Class I Recall Issued for Transcatheter Heart Valve Delivery System
Edwards Lifesciences is recalling their SAPIEN 3 Ultra delivery system, the system is part of the Edwards SAPIEN 3 Transcatheter Heart Valve System.
Bempedoic Acid Plus Ezetimibe Lowers LDL-C When Added to Maximally Tolerated Statin Therapy
Fixed-dose bempedoic acid with ezetimibe lowered LDL-C vs placebo when added to maximally tolerated statin therapy in patients with high CVD risk and hypercholesterolemia.
AHA: Prescription Omega-3 Fatty Acids Effectively Lower Triglycerides
After any underlying causes are addressed and diet and lifestyle strategies are implemented, prescription omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid or EPA only, at a dose of 4 g/day are effective for lowering triglycerides as monotherapy or in combination with other agents.
Cholesterol Management Guidelines
Recommendations from the American College of Cardiology/American Heart Association Task Force on the management of blood cholesterol.
